Plain-English translation of NCT01000259 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand whether certain immune cells found inside ovarian cancer tumors can predict how long patients will survive and stay cancer-free after treatment. This study uses tumor tissue samples that were already collected during surgery—no new procedures are needed. The researchers will examine these tissue samples under a microscope using special staining techniques to count and measure immune cells and see if they're connected to better or worse outcomes.
Some people with advanced ovarian cancer respond better to treatment than others, but doctors don't yet have a reliable way to predict who will do well. If researchers can show that certain immune cells in the tumor predict outcomes, this could help doctors personalize treatment plans and give patients better information about what to expect.
You likely qualify if…
You likely don't qualify if…
In this study, you don't need to visit a clinic or undergo any new procedures. Researchers will use tumor tissue samples that were already removed and stored during your cancer surgery. They will examine these samples in the laboratory using special staining and imaging techniques to look at immune cells. The study simply involves analyzing your existing tissue samples and reviewing your medical records and follow-up information that was already collected.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
United States
Sponsor
Gynecologic Oncology Group
Collaborators
National Cancer Institute (NCI)
Enrollment target
~174 participants
Started
September 2004
Primary completion
January 2100
Sex
Female only
Last updated on clinicaltrials.gov in May 2017.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.